Management of Macrocytosis with Normal B12 and Folate Levels

Common Causes of Macrocytosis with Normal B12/Folate

Medication-induced macrocytosis can occur through myelosuppressive activity rather than vitamin deficiency, particularly with thiopurines such as azathioprine and 6-mercaptopurine, in patients with conditions like Crohn's disease or ulcerative colitis 1, 2
Reticulocytosis, characterized by an increased reticulocyte count from hemolysis or recent hemorrhage, can elevate MCV in patients with various underlying conditions 1

A reticulocyte count is critical for distinguishing between ineffective erythropoiesis and increased red cell production, with low/normal reticulocytes suggesting deficiency or bone marrow disorder, and elevated reticulocytes suggesting hemolysis or recent hemorrhage, in patients with macrocytosis 1
Red cell morphology abnormalities, including the presence of schistocytes, can be evaluated through peripheral blood smear to suggest hemolysis in patients with macrocytosis 1, 3
Hemolysis evaluation, including tests such as haptoglobin, LDH, and bilirubin, can be useful if hemolysis is suspected in patients with macrocytosis 1

Identifying and addressing the underlying cause of macrocytosis is crucial, including medication review and discussion of risk/benefit with the prescribing physician for patients on medications known to cause macrocytosis, such as azathioprine or 6-mercaptopurine 1, 2
Regular CBC monitoring is necessary to track MCV and ensure stability in patients with macrocytosis, with reassessment of B12 and folate levels periodically, even with initially normal levels, as deficiencies may develop over time 1, 4
Consideration of hematology consultation is recommended if the cause of macrocytosis remains unclear after initial workup, or if there are other concerning hematologic abnormalities, such as severe or progressively worsening macrocytosis 1, 3

Mixed nutrient deficiencies, such as microcytosis from iron deficiency coexisting with macrocytosis, can result in a falsely normal MCV, and can be identified by elevated red cell distribution width (RDW) in patients with macrocytosis 1
Patients with inflammatory bowel disease (IBD) require special attention, as they are at risk for multiple nutritional deficiencies, and macrocytosis may be due to medication effects rather than vitamin deficiency 2, 5

The presence of other cytopenias, particularly anemia, increases the diagnostic yield for bone marrow disorders, and thus, a bone marrow evaluation should be considered in such cases, especially in elderly patients with unexplained, persistent macrocytosis 6

Neglecting follow-up is a common pitfall, as even unexplained macrocytosis requires monitoring, given that a significant percentage of patients may develop primary bone marrow disorders or worsening cytopenias over time, although the specific percentage is not provided in the cited reference 6

MCH is more sensitive for iron deficiency than MCV and may detect iron deficiency even when macrocytosis masks the expected microcytosis 7
A reduced MCH in the setting of macrocytosis suggests a mixed picture that requires further investigation, as it may indicate concurrent iron deficiency that would otherwise be masked by the elevated MCV 7

In patients with inflammatory bowel disease (IBD) and other chronic inflammatory conditions, MCH evaluation is particularly important as these patients often have mixed nutrient deficiencies 8, 9
When macrocytosis is present but MCH is reduced (hypochromia), this suggests a mixed picture of micro- and macrocytosis, which is important to recognize as treatment approaches differ 9

If MCH is low despite macrocytosis: Check iron studies (ferritin, transferrin saturation) 7

In patients with inflammatory conditions, serum ferritin up to 100 μg/L may still be consistent with iron deficiency, making MCH assessment even more valuable 8, 9
For patients on thiopurine therapy (e.g., azathioprine), macrocytosis is common but should not prevent evaluation of MCH to detect concurrent iron deficiency 9
Not considering that chronic inflammation can affect both iron metabolism and MCH values, requiring adjustment of diagnostic thresholds 8, 9

Elevated homocysteine levels may reveal tissue deficiency of B12 or folate despite normal serum levels, according to the American Journal of Kidney Diseases 10
Methylmalonate is specific for B12 deficiency with better sensitivity than serum B12 measurement, as noted by the Journal of Crohn's and Colitis 11
In patients with inflammatory bowel disease, special attention is required due to the risk for multiple nutritional deficiencies, as highlighted by the Journal of Crohn's and Colitis 11